Skip to main content
HR 4866 116th Congress House Health Advanced technology and technological innovations Congressional oversight Drug safety, medical device, and laboratory regulation Government information and archives Health programs administration and funding Health technology, devices, supplies Higher education Manufacturing Prescription drugs Product development and innovation Research administration and funding Research and development

National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020

Introduced: October 28, 2019 Introduced by: Pallone, Frank Democratic · New Jersey See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 16 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 22, 2020
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sep 21, 2020
Mrs. Dingell moved to suspend the rules and pass the bill, as amended.
Sep 21, 2020
Considered under suspension of the rules. (consideration: CR H4616-4618)
Sep 21, 2020
DEBATE - The House proceeded with forty minutes of debate on H.R. 4866.
Sep 21, 2020
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
Sep 21, 2020
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4616-4617)
Sep 21, 2020
Motion to reconsider laid on the table Agreed to without objection.
Sep 17, 2020
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-513.
Sep 17, 2020
Placed on the Union Calendar, Calendar No. 413.
Jul 15, 2020
Committee Consideration and Mark-up Session Held.
Jul 15, 2020
Ordered to be Reported (Amended) by Voice Vote.
Mar 11, 2020
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Mar 11, 2020
Subcommittee Consideration and Mark-up Session Held.
Oct 29, 2019
Referred to the Subcommittee on Health.
Oct 28, 2019
Referred to the House Committee on Energy and Commerce.
Oct 28, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2019

This bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education as National Centers of Excellence in Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on continuous manufacturing technologies and must share information from such research with the FDA. (Currently, most drug production involves batch manufacturing, which typically takes longer than continuous manufacturing processes.)

What's happening now September 22, 2020

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 3
  • HR 6379 Related bill Workforce Emergency Response Act of 2020
  • HR 6800 Related bill The Heroes Act
  • HR 14 Related bill Commitment to Defeat the Virus and Keep America Healthy Act
 Bill text 4 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 3
 Cosponsors 1
All 1 Republican 1
R
Guthrie, Brett
Kentucky · Oct 28, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4866: National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020. 116th Congress. Open America. https://openamerica.io/bill/116-HR-4866/
MLA
"H.R. 4866: National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-4866/.
Bluebook (legal)
H.R. 4866, 116th Cong. (2026), https://openamerica.io/bill/116-HR-4866/.
Markdown link
[H.R. 4866: National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020](https://openamerica.io/bill/116-HR-4866/)
Report a problem